|
Corindus Vascular Robotics, Inc |
|
|
11 Erie Dr.
Natick, MA 01760 USA
phone:(508) 653-3335
fax:(508) 653-3355
|
|
| Symbol |
Private |
| Founded |
2007 |
| Employees |
16 |
|
|
| www.corindus.com
|
|
|
|
 |
| Summary Description |
| Vascular robotics for PCI procedures |
|
| Management |
| David M. Handler, President and CEO; Tal Wenderow, Co-Founder, Chief Technology Officer & Vice President of Business Development; Tom Bromander, Vice President of Research and Development; Erik Bates, Vice President of Operations; Paul Pelletier, Director of Quality Assurance; Michail Pankratov, MD, PhD, Vice President of Clinical and Regulatory Affairs; Eamonn Fahy, Director of Finance |
| |
|
|
| |
|
| Keywords |
| Vascular robotics, PCI, percutaneous coronary intervention |
|
|
|
| Description |
|
Corindus designs, manufactures and commercializes precision vascular robotic systems for use in minimally invasive procedures. |
|
| Products / Services |
The Companys initial product, the CorPath 200 system, is the worlds first to precisely drive coronary guidewires and stent/balloon catheters during percutaneous coronary intervention (PCI) procedures performed in a cath lab.
|
|
| Technology / Differentiation |
| Precise device manipulation is a key challenge in PCI procedures today. Via CorPaths stability and precision-controlled movements, the system empowers interventional cardiologists to improve their accuracy and potentially improve clinical outcomes in PCI procedures. Currently, these procedures are performed manually and rely on the variable dexterity of a physicians hands while standing bedside in a hazardous and stressful environment. |
|
| Market / Customers |
Currently, PCI procedures are performed in a cath lab using x-ray angiography imaging, which exposes physicians to significant occupational hazardsincluding (1) radiation exposure (cancer, cataracts), as well as (2) chronic orthopedic ailments (spine) and fatigue due to the required use of heavy lead-protection garments. Indeed, there are many published studies showing that the cath lab is a hazardous work environment. For the first time in a cath lab, the CorPath system significantly reduces radiation exposure, fatigue, and other occupational hazards by protecting physicians from radiation and allowing them to operate in an ergonomically correct position.
|
|
| Status |
| First-in-man study completed March 2010 with CorPath 200 system. Regulatory clearances will be initiated in 2010. |
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members